Can omeprazole reduce the incidence of hypercalcemia in dialysis patients using calcium containing phosphate binders?
Conclusions: While theoretically advantageous, we found that omeprazole had little clinical benefit in reducing hypercalcemia in a population who are unable to afford non-calcium-based binders; however, further studies may be warranted.
PMID: 20349423 [PubMed - as supplied by publisher] (Source: Journal of Nephrology)